667, L.P.
Director, 10% Owner · 4 filings · Latest: May 8, 2026
INCYTE CORP
Prelude Therapeutics Inc
Replimune Group, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
INCY | 667, L.P. | Director, 10% Owner | May 8, 2026 | Option Exercise | $84.53 | 30,000 | $2.5M | 28,203,718 | |
TARA | 667, L.P. | — | Apr 23, 2026 | Proposed Sale | $5.35 | 24,802 | $132.7K | — | |
TARA | 667, L.P. | — | Mar 6, 2026 | Proposed Sale | $5.85 | 38,277 | $223.9K | — | |
TARA | 667, L.P. | — | Mar 4, 2026 | Proposed Sale | $6.26 | 35,173 | $220.2K | — | |
TARA | 667, L.P. | — | Feb 25, 2026 | Proposed Sale | $5.81 | 78,716 | $457.0K | — | |
TARA | 667, L.P. | — | Feb 24, 2026 | Proposed Sale | $6.04 | 26,755 | $161.6K | — | |
ONC | 667, L.P. | — | Feb 28, 2025 | Proposed Sale | $260.00 | 60,851 | $15.8M | — | |
ONC | 667, L.P. | — | Dec 9, 2024 | Proposed Sale | $187.27 | 86,110 | $16.1M | — |